|
Fördröjd
Andra börsplatser
|
5-dagars förändring | Förändring 1 jan. | ||
| 3,600 CAD | 0,00 % |
|
+5,88 % | −46,27 % |
| Skatteperiod: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Lönsamhet | ||||||||
Return on Assets | −55,3 | −40,06 | −34,16 | −9,62 | −7,93 | |||
Return on Total Capital | −171,78 | −51,29 | −44,52 | −13,61 | −9,68 | |||
Return On Equity % | −373,46 | −51,05 | −80,07 | −4,59 | −4,47 | |||
Return on Common Equity | −368,83 | −48,73 | −89,55 | −39,57 | −20,88 | |||
Marginalanalys | ||||||||
Gross Profit Margin % | 61,73 | 82,34 | 87,71 | 88,96 | 89,93 | |||
SG&A Margin | 3,16 tn | 267,57 | 102,4 | 87,93 | 91,14 | |||
EBITDA Margin % | −3,79 tn | −243,49 | −27,6 | −4,12 | −4,56 | |||
EBITA Margin % | −3,82 tn | −244,86 | −27,85 | −4,24 | −4,72 | |||
EBIT Margin % | −3,82 tn | −244,86 | −27,85 | −4,24 | −4,72 | |||
Income From Continuing Operations Margin % | −5,15 tn | −151,97 | −31,1 | −0,89 | −1,28 | |||
Net Income Margin % | −5,13 tn | −147,09 | −34,41 | −6,23 | −4,22 | |||
Net Avail. For Common Margin % | −5,13 tn | −147,09 | −34,41 | −6,23 | −4,22 | |||
Normalized Net Income Margin | −3,2 tn | −90,07 | −21,77 | −3,39 | −2,06 | |||
Levered Free Cash Flow Margin | −3,78 tn | −244,06 | −5,27 | −0,75 | 0,84 | |||
Unlevered Free Cash Flow Margin | −3,78 tn | −244,01 | −5,27 | −0,73 | 0,85 | |||
Tillgångsomslutning | ||||||||
Asset Turnover | 0,02 | 0,26 | 1,96 | 3,63 | 2,69 | |||
Fixed Assets Turnover | 3,56 | 33,67 | 116,73 | 236,44 | 267,46 | |||
Receivables Turnover (Average Receivables) | - | - | 87,83 | 117,98 | 112,52 | |||
Inventory Turnover (Average Inventory) | 0,16 | 0,55 | 1,17 | 1,28 | 0,98 | |||
Kortfristig likviditet | ||||||||
Current Ratio | 3,51 | 9,41 | 2,68 | 4,09 | 7,7 | |||
Quick Ratio | 3,15 | 7,1 | 1,8 | 2,48 | 5,63 | |||
Operating Cash Flow to Current Liabilities | −1,86 | −8,3 | −1,54 | −0,71 | 0,37 | |||
Days Sales Outstanding (Average Receivables) | - | - | 4,16 | 3,1 | 3,24 | |||
Days Outstanding Inventory (Average Inventory) | 2,29 tn | 662,57 | 312,83 | 285,14 | 374,12 | |||
Average Days Payable Outstanding | 682,9 | 25,17 | 16,46 | 11,28 | 49,68 | |||
Cash Conversion Cycle (Average Days) | - | - | 300,52 | 276,97 | 327,69 | |||
Långsiktig solvens | ||||||||
Total Debt/Equity | 0,01 | 0,55 | 0,75 | 0,14 | 11,29 | |||
Total Debt / Total Capital | 0,01 | 0,54 | 0,75 | 0,14 | 10,14 | |||
LT Debt/Equity | - | 0,32 | 0,25 | - | 11,29 | |||
Long-Term Debt / Total Capital | - | 0,32 | 0,25 | - | 10,14 | |||
Total Liabilities / Total Assets | 28,34 | 10,77 | 36,8 | 24,17 | 21,72 | |||
EBIT / Interest Expense | −575,38 | −3,13 tn | - | −178,14 | −418,33 | |||
EBITDA / Interest Expense | −572,08 | −3,12 tn | - | −173,14 | −404,33 | |||
(EBITDA - Capex) / Interest Expense | −575,23 | −3,13 tn | - | −175,29 | −409,67 | |||
Total Debt / EBITDA | −0 | −0,01 | −0,01 | −0,01 | −0,77 | |||
Net Debt / EBITDA | 1,49 | 0,79 | 1,02 | 4,12 | 4,75 | |||
Total Debt / (EBITDA - Capex) | −0 | −0,01 | −0,01 | −0,01 | −0,76 | |||
Net Debt / (EBITDA - Capex) | 1,48 | 0,79 | 1,01 | 4,07 | 4,68 | |||
Tillväxt jämfört med föregående år | ||||||||
Total Revenues, 1 Yr. Growth % | 2,35 tn | 1,21 tn | 433,68 | 115,55 | −9,6 | |||
Gross Profit, 1 Yr. Growth % | 3,93 tn | 1,64 tn | 468,49 | 118,63 | −8,62 | |||
EBITDA, 1 Yr. Growth % | 58,74 | −16,22 | −39,5 | −67,85 | 0,08 | |||
EBITA, 1 Yr. Growth % | 58,31 | −16,23 | −39,31 | −67,21 | 0,64 | |||
EBIT, 1 Yr. Growth % | 58,31 | −16,23 | −39,31 | −67,21 | 0,64 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | 1,39 | −61,46 | 9,23 | −93,83 | 30,15 | |||
Net Income, 1 Yr. Growth % | 0,94 | −62,54 | 24,87 | −60,98 | −38,71 | |||
Normalized Net Income, 1 Yr. Growth % | 0,68 | −63,2 | 28,99 | −66,45 | −45,01 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | −27,16 | −66,21 | 20,96 | −64,19 | −41,02 | |||
Accounts Receivable, 1 Yr. Growth % | - | - | 301,61 | 0,4 | −10,8 | |||
Inventory, 1 Yr. Growth % | 18,6 | 121,76 | 54,46 | 89,87 | −34,31 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | −3,57 | 81,48 | 38,78 | −16,91 | −23,89 | |||
Total Assets, 1 Yr. Growth % | 190,15 | −44,52 | −0,52 | 33,43 | 13,63 | |||
Tangible Book Value, 1 Yr. Growth % | −351,04 | −29,39 | −35,83 | 25,93 | 8,36 | |||
Common Equity, 1 Yr. Growth % | −351,04 | −29,39 | −35,83 | 25,93 | 8,36 | |||
Cash From Operations, 1 Yr. Growth % | 79,79 | −8,48 | −35,65 | −59,55 | −131,35 | |||
Capital Expenditures, 1 Yr. Growth % | - | −36,59 | 76,92 | −67,39 | 6,67 | |||
Levered Free Cash Flow, 1 Yr. Growth % | −284,93 | −15,68 | −88,47 | −69,47 | −201,82 | |||
Unlevered Free Cash Flow, 1 Yr. Growth % | −284,5 | −15,61 | −88,47 | −70,08 | −204,76 | |||
Sammansatt Årlig Tillväxthastighet Över Två År | ||||||||
Total Revenues, 2 Yr. CAGR % | - | 1,69 tn | 734,74 | 239,17 | 39,59 | |||
Gross Profit, 2 Yr. CAGR % | - | 2,55 tn | 894,95 | 252,54 | 41,35 | |||
EBITDA, 2 Yr. CAGR % | 58,03 | 15,33 | −28,8 | −55,9 | −43,28 | |||
EBITA, 2 Yr. CAGR % | 57,88 | 15,16 | −28,7 | −55,39 | −42,55 | |||
EBIT, 2 Yr. CAGR % | 57,88 | 15,16 | −28,7 | −55,39 | −42,55 | |||
Earnings From Cont. Operations, 2 Yr. CAGR % | 73,95 | −37,49 | −35,12 | −74,04 | −71,67 | |||
Net Income, 2 Yr. CAGR % | 73,57 | −38,5 | −31,6 | −30,2 | −51,1 | |||
Normalized Net Income, 2 Yr. CAGR % | 73,34 | −39,13 | −31,1 | −34,21 | −57,04 | |||
Diluted EPS Before Extra, 2 Yr. CAGR % | 27,23 | −50,39 | −36,07 | −34,19 | −54,04 | |||
Accounts Receivable, 2 Yr. CAGR % | - | 456,78 | - | 100,8 | −5,36 | |||
Inventory, 2 Yr. CAGR % | - | 62,18 | 85,08 | 71,25 | 11,68 | |||
Net Property, Plant and Equip., 2 Yr. CAGR % | −24,61 | 32,29 | 58,7 | 7,38 | −20,48 | |||
Total Assets, 2 Yr. CAGR % | 120,69 | 26,87 | −25,71 | 15,21 | 23,13 | |||
Tangible Book Value, 2 Yr. CAGR % | 153,15 | 33,14 | −32,69 | −10,11 | 16,82 | |||
Common Equity, 2 Yr. CAGR % | 153,15 | 33,14 | −32,69 | −10,11 | 16,82 | |||
Cash From Operations, 2 Yr. CAGR % | 56,26 | 28,28 | −23,26 | −48,98 | −64,39 | |||
Capital Expenditures, 2 Yr. CAGR % | 113,44 | - | 5,92 | −24,04 | −41,02 | |||
Levered Free Cash Flow, 2 Yr. CAGR % | 176,69 | 24,86 | −68,83 | −81,24 | −44,25 | |||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 180,19 | 24,77 | −68,81 | −81,43 | −44,02 | |||
Treårig Sammansatt Årlig Tillväxthastighet | ||||||||
Total Revenues, 3 Yr. CAGR % | - | - | 1,1 tn | 431,55 | 118,27 | |||
Gross Profit, 3 Yr. CAGR % | - | - | 1,49 tn | 500,39 | 124,78 | |||
EBITDA, 3 Yr. CAGR % | - | 27,9 | −6,99 | −45,38 | −42,04 | |||
EBITA, 3 Yr. CAGR % | 55,25 | 27,81 | −6,98 | −44,96 | −41,49 | |||
EBIT, 3 Yr. CAGR % | 55,25 | 27,81 | −6,98 | −44,96 | −41,49 | |||
Earnings From Cont. Operations, 3 Yr. CAGR % | 70,29 | 5,26 | −24,71 | −70,39 | −55,57 | |||
Net Income, 3 Yr. CAGR % | 70,04 | 4,12 | −22,13 | −43,27 | −33,16 | |||
Normalized Net Income, 3 Yr. CAGR % | 69,89 | 3,41 | −21,81 | −45,79 | −38,03 | |||
Diluted EPS Before Extra, 3 Yr. CAGR % | 22,75 | −18,22 | −33,23 | −47,3 | −36,55 | |||
Accounts Receivable, 3 Yr. CAGR % | - | - | 399,33 | - | 53,22 | |||
Inventory, 3 Yr. CAGR % | - | - | 59,57 | 86,66 | 24,43 | |||
Net Property, Plant and Equip., 3 Yr. CAGR % | 162,07 | 1,04 | 34,42 | 27,91 | −4,26 | |||
Total Assets, 3 Yr. CAGR % | 167,09 | 39,28 | 16,99 | −9,7 | 14,68 | |||
Tangible Book Value, 3 Yr. CAGR % | 314,66 | 65,4 | 4,39 | −17,06 | −4,33 | |||
Common Equity, 3 Yr. CAGR % | 314,66 | 65,4 | 4,39 | −17,06 | −4,33 | |||
Cash From Operations, 3 Yr. CAGR % | 62,03 | 30,74 | 1,92 | −38,01 | −56,63 | |||
Capital Expenditures, 3 Yr. CAGR % | 99,77 | 42,42 | - | −28,48 | −14,94 | |||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 86,19 | −43,57 | −69,04 | −67,03 | |||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 87,81 | −43,59 | −69,24 | −66,94 | |||
Sammansatt Årlig Tillväxthastighet Över Fem År | ||||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | 406,29 | |||
Gross Profit, 5 Yr. CAGR % | - | - | - | - | 503,07 | |||
EBITDA, 5 Yr. CAGR % | - | - | - | −16,46 | −23,68 | |||
EBITA, 5 Yr. CAGR % | - | - | 13,73 | −16,11 | −23,29 | |||
EBIT, 5 Yr. CAGR % | - | - | 13,73 | −16,11 | −23,29 | |||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 15,76 | −39,88 | −49,07 | |||
Net Income, 5 Yr. CAGR % | - | - | 18,13 | −11,27 | −35,35 | |||
Normalized Net Income, 5 Yr. CAGR % | - | - | 18,41 | −13,7 | −38,47 | |||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | −5,44 | −25,02 | −42,5 | |||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 156,72 | |||
Inventory, 5 Yr. CAGR % | - | - | - | - | 38,34 | |||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 114,43 | 3,53 | 8,96 | |||
Total Assets, 5 Yr. CAGR % | - | - | 60,09 | 29,1 | 19,41 | |||
Tangible Book Value, 5 Yr. CAGR % | - | - | 100,38 | 29,6 | 9,19 | |||
Common Equity, 5 Yr. CAGR % | - | - | 100,38 | 29,6 | 9,19 | |||
Cash From Operations, 5 Yr. CAGR % | - | - | 20,16 | −10,27 | −33,08 | |||
Capital Expenditures, 5 Yr. CAGR % | - | - | 54,99 | 10,76 | - | |||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | −25,66 | −43,84 | |||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | −25,57 | −43,76 |
- Börsen
- Aktier
- INNO Aktie
- Finanser InnoCan Pharma Corporation
- Finansiella nyckeltal
Välj din utgåva
All finansiell information anpassad till den nationella nivån
















